[1]江海燕,杨 敏,江 雪,等.结核性胸膜炎合并肺部感染病原菌特点、耐药性及影响因素分析[J].陕西医学杂志,2023,52(12):1740-1743,1748.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.025]
 JIANG Haiyan,YANG Min,JIANG Xue,et al.Characteristics,drug resistance and influencing factors of pathogenic bacteria in tuberculous pleuritis complated with pulmonary infection[J].,2023,52(12):1740-1743,1748.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.025]
点击复制

结核性胸膜炎合并肺部感染病原菌特点、耐药性及影响因素分析
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年12期
页码:
1740-1743,1748
栏目:
临床检验
出版日期:
2023-12-05

文章信息/Info

Title:
Characteristics,drug resistance and influencing factors of pathogenic bacteria in tuberculous pleuritis complated with pulmonary infection
作者:
江海燕1杨 敏1江 雪2邓 强1颜 璐1
(1.广安市人民医院检验科,四川 广安 638000; 2.广安市人民医院急诊科,四川 广安 638000)
Author(s):
JIANG HaiyanYANG MinJIANG XueDENG QiangYAN Lu
(Department of Laboratory,Guang'an People's Hospital,Guang'an 638000,China)
关键词:
结核性胸膜炎 肺部感染 革兰阳性菌 革兰阴性菌 耐药性 影响因素
Keywords:
Tuberculous pleuritis Pulmonary infection Gram-positive bacteria Gram-negative bacteria Drug resistance Influencing factor
分类号:
R 521.7
DOI:
DOI:10.3969/j.issn.1000-7377.2023.12.025
文献标志码:
A
摘要:
目的:探究结核性胸膜炎合并肺部感染病原菌特点、耐药性及影响因素。方法:选取结核性胸膜炎疑似肺部感染患者200例为研究对象,以痰液培养结果分为感染组(132例)和未感染组(68例)。采集肺部感染者痰液标本并进行药敏试验,分析病原菌分布及其耐药性。收集患者临床资料,分析影响肺部感染发生的危险因素。结果:103例结核性胸膜炎合并肺部感染患者的痰液中共分离出138株病原菌,其中革兰阴性菌88株(63.77%),革兰阳性菌42株(30.43%),真菌8株(5.80%)。革兰阴性菌对氨苄西林(93.18%)、左氧氟沙星(59.09%)、磺胺甲恶唑(50.00%)等耐药率较高; 革兰阳性菌对青霉素(90.48%)、红霉素(66.67%)、利福平(50.00%)耐药率较高; 真菌对酮康唑(100.00%)、氟康唑(87.50%)、伏立康唑(62.50%)耐药率较高。在革兰阴性菌的抗生素中,与氨苄西林比较,其他抗生素的耐药率较低(均P<0.05)。在革兰阳性菌的抗生素中,与青霉素比较,其他抗生素的耐药率较低(均P<0.05)。在真菌的抗生素中,与酮康唑比较,仅有两性霉素B耐药性较低(P<0.05)。Logistic回归性分析结果显示,年龄>60岁、合并糖尿病、侵入性操作、长期使用糖皮质激素和广谱抗生素为结核性胸膜炎合并肺部感染发生的独立危险因素(均P<0.05)。结论:结核性胸膜炎合并肺部感染病原菌主要以革兰阴性菌为主,且对多种药物产生耐药性。年龄>60岁、合并糖尿病、侵入性操作、长期使用糖皮质激素和广谱抗生素均为肺部感染发生的危险因素。
Abstract:
Objective:To explore the characteristics,drug resistance and influencing factors of pathogenic bacteria in tuberculous pleuritis complated with pulmonary infection.Methods:A total of 200 tuberculous pleuritis patients with suspected pulmonary infection were selected as research subjects.According to the results of sputum culture,they were divided into infection group(132 cases)and non-infection group(68 cases).Sputum samples were collected from patients with pulmonary infection and drug sensitivity test was performed to analyze the distribution and drug resistance of pathogens.The clinical data of the patients were collected,and the risk factors affecting the occurrence of pulmonary infection were analyzed.Results:A total of 138 pathogenic bacteria were isolated from the sputum of 103 patients with tuberculous pleuritis complicated with pulmonary infection,including 88 Gram-negative bacteria(63.77%),42 Gram-positive bacteria(30.43%),and 8 fungi(5.80%).Gram-negative bacteria had high resistance rates to ampicillin(93.18%),levofloxacin(59.09%),and sulfamethoxazole(50.00%).Gram-positive bacteria had high resistance rates to penicillin(90.48%),erythromycin(66.67%)and rifampicin(50.00%).Fungi had high resistance rates to ketoconazole(100.00%),fluconazole(87.50%)and voriconazole(62.50%).Among the antibiotics for Gram-negative bacteria,compared with ampicillin,other antimicrobial resistance were lower(all P<0.05).Among the antibiotics for Gram-positive bacteria,the resistance rates of other antibiotics were lower than those of penicillin(all P<0.05).Among the antibiotics for fungi,compared with ketoconazole,the drug resistance of amphotericin B was significantly lower(P<0.05).Conclusion:Gram-negative bacteria are the main pathogens of tuberculous pleuritis complicated with pulmonary infection,and they are resistant to many drugs.Age >60 years,diabetes mellitus,invasive operation,long-term use of glucocorticoids and broad-spectrum antibiotics are risk factors for pulmonary infection.

参考文献/References:

[1] 卢映宏,史文佩,胡 屹,等.肺结核患者与健康人群肠道菌群差异及其生物标志物的比较研究[J].中华结核和呼吸杂志,2021,44(11):939-946.
[2] 刘 媛,剧 猛,左 蕾,等.结核性胸膜炎合并2型糖尿病患者外周血及胸腔积液结核感染T细胞斑点试验检测结果的对比研究[J].中国防痨杂志,2022,44(5):489-493.
[3] Shaw JA,Koegelenberg CFN.Pleural tuberculosis[J].Clin Chest Med,2021,42(4):649-666.
[4] 方 圆,赵 峰,陈 佩,等.胸腔积液结核分枝杆菌感染T细胞检测对结核性胸膜炎的诊断价值研究[J].陕西医学杂志,2020,49(12):1681-1683,1687.
[5] 谢 平,陈彩萍,刘亮明.结核性胸膜炎分子及生化免疫学诊断研究进展[J].中华临床感染病杂志,2020,13(5):387-393.
[6] 赵 婷,孙长峰,肖 科,等.肺结核患者合并其他病原菌肺部感染的临床特点及危险因素分析[J].中国感染与化疗杂志,2020,113(3):22-27.
[7] 李顺丽,刘 洋.肺结核患者住院期间并发肺部感染的高危因素分析[J].中国医药导报,2020,17(10):102-104,133.
[8] 彭卫生,王英年,肖成志.新编结核病学[M].2版.北京:中国医药科技出版社,2003:25-31.
[9] 陈 红.肺部感染性疾病的诊治进展[M].天津:天津科学技术出版社,2011:79-83.
[10] 尚 红,王毓三,申子瑜.全国临床检验操作规程[M].2版.北京:人民卫生出版社,2015:79-84.
[11] 辛 敏,杨洪利.肺结核合并肺癌患者医院感染的病原学分析与护理策略[J].中国肿瘤临床与康复,2020,27(10):119-121.
[12] 刘 莉,李 晋,马 云,等.肺结核348例耐药情况调查及影响因素分析[J].陕西医学杂志,2021,50(5):626-629,633.
[13] 夏 琴.肺泰胶囊联合利奈唑胺治疗广泛性耐药结核病疗效研究[J].陕西中医,2019,40(4):469-471.
[14] 李瑞雪,罗 浩,张育泉,等.结核性胸膜炎临床诊断的研究进展[J].临床误诊误治,2021,34(4):103-109.
[15] Athimni S,Slouma M,Dhahri R,et al.Tuberculosis infection under anti-TNF alpha treatment[J].Curr Drug Saf,2022,17(3):235-240.
[16] 高 娴,李洪智,杨 洁.滋阴润肺抗痨方中药雾化治疗对耐多药肺结核病理状态改善效应及对患者细胞免疫功能的影响[J].陕西中医,2020,41(2):187-190.
[17] 高卫卫,胡炜燚,徐元龙,等.胸膜结核瘤发病机制及治疗的研究进展[J].国际呼吸杂志,2021,41(20):1521-1525.
[18] 程国栋,王海玲,王玉清.肺结核患者合并肺部感染病原菌的种类、血清蛋白水平及分枝杆菌耐药性分析[J].中国病原生物学杂志,2020,158(2):99-102.
[19] 张 培,蔺 昕,林 康,等.肺癌合并肺部感染患者病原菌分布、耐药性分析及血清炎性因子检测的临床意义[J].现代生物医学进展,2021,21(9):1682-1686.
[20] 朱彩凤,杨彩红,李梅华,等.血流感染合并肺部感染患者的临床特征,预后及其影响因素[J].广西医学,2020,42(13):1625-1629.
[21] 杨子龙,袁 园,汪 敏,等.糖尿病与肺结核共病结核分枝杆菌耐药情况分析[J].实用医学杂志,2023,39(11):1359-1363.
[22] 程 洁,王殿超,彭 玲,等.肺结核并发肺部感染患者的病原菌分布特点及其相关影响因素分析[J].药物生物技术,2022,29(3):267-270.
[23] 唐燕君,冉丽萍,张中杨,等.肺结核合并肺部感染患者病原菌分布及内毒素、钙结合蛋白检测的临床意义[J].实用医院临床杂志,2022,19(1):112-115.

相似文献/References:

[1]漆 沄,谢 君,李卫星,等.肺康复训练对结核性胸膜炎患者肺功能影响的临床研究*[J].陕西医学杂志,2019,(10):1319.
 QI Yun,XIE Jun,LI Weixing,et al.Clinical observation of pulmonary rehabilitation training on 〖JZ〗lpumonary function in patients with tuberculous pleurisy[J].,2019,(12):1319.
[2]方 圆,赵 峰,陈 佩,等.胸腔积液结核分枝杆菌感染T细胞检测对结核性胸膜炎的诊断价值研究*[J].陕西医学杂志,2020,49(12):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
 FANG Yuan,ZHAO Feng,CHEN Pei,et al.Value of T-SPOT.TB assay from pleural fIuid in diagnosis of tuberculous pleurisy[J].,2020,49(12):1681.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.038]
[3]魏永梅,马俊彦,李 阳,等.纤维支气管镜肺泡灌洗治疗支气管扩张合并肺部感染临床疗效Meta分析[J].陕西医学杂志,2021,50(7):893.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.033]
[4]薛 昭,张卓红.肺癌新辅助化疗患者血清C-反应蛋白、降钙素原和细胞角蛋白19片段抗原表达与肺部感染严重程度评分关系[J].陕西医学杂志,2022,51(10):1227.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.012]
 XUE Zhao,ZHANG Zhuohong.Correlation between expression levels of serum CRP,PCT,CYFRA21-1 and severity score of pulmonary infection in patients with lung cancer undergoing neoadjuvant chemotherapy[J].,2022,51(12):1227.[doi:DOI:10.3969/j.issn.1000-7377.2022.10.012]
[5]杜 晶,张竹青,马春梅,等.老年急性呼吸衰竭合并肺部感染患者病原菌分布特点、耐药性及血清白介素-6、白介素-10水平变化临床意义[J].陕西医学杂志,2023,52(10):1354.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.015]
 DU Jing,ZHANG Zhuqing,MA Chunmei,et al.Distribution and drug resistance of pathogenic bacteria in elderly patients with acute respiratory failure complicated with pulmonary infection and clinical significance of changes in serum IL-6 and IL-10 levels[J].,2023,52(12):1354.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.015]
[6]王建爱,于 蕾,罗育红,等.冠心病合并肺部感染患者血清IL-6、PCT水平变化及与心肌酶学、肺炎严重程度相关性研究[J].陕西医学杂志,2023,52(11):1554.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.022]
[7]张晓光,党 萍,霍 琳,等.衔接蛋白失能同源物2通过抑制NOD样受体热蛋白结构域相关蛋白3对结核性胸膜炎大鼠炎症和氧化应激的影响[J].陕西医学杂志,2024,(4):468.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.007]
 ZHANG Xiaoguang,DANG Ping,HUO Lin,et al.Effects of adaptor protein disabling homologue 2 on inflammation and oxidative stress in rats with tuberculous pleurisy by inhibiting NLRP3[J].,2024,(12):468.[doi:DOI:10.3969/j.issn.1000-7377.2024.04.007]

备注/Memo

备注/Memo:
基金项目:四川省卫生和计划生育委员会科研课题(17PJ090)
更新日期/Last Update: 2023-12-05